Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits
针对淀粉样蛋白 β 1-42 寡聚体的阿尔茨海默病治疗 I：Abeta 42 寡聚体与特定神经元受体的结合被改善认知缺陷的候选药物所取代
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0111898
Nicholas J Izzo, Agnes Staniszewski, Lillian To, Mauro Fa, Andrew F Teich, Faisal Saeed, Harrison Wostein, Thomas Walko 3rd, Anisha Vaswani, Meghan Wardius, Zanobia Syed, Jessica Ravenscroft, Kelsie Mozzoni, Colleen Silky, Courtney Rehak, Raymond Yurko, Patricia Finn, Gary Look, Gilbert Rishton, Han
